Details for New Drug Application (NDA): 019928
✉ Email this page to a colleague
The generic ingredient in CARDIOTEC is technetium tc-99m teboroxime kit. There are four drug master file entries for this compound. Additional details are available on the technetium tc-99m teboroxime kit profile page.
Summary for 019928
Tradename: | CARDIOTEC |
Applicant: | Bracco |
Ingredient: | technetium tc-99m teboroxime kit |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | N/A | ||||
Approval Date: | Dec 19, 1990 | TE: | RLD: | No |
Expired US Patents for NDA 019928
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bracco | CARDIOTEC | technetium tc-99m teboroxime kit | INJECTABLE;INJECTION | 019928-001 | Dec 19, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
Bracco | CARDIOTEC | technetium tc-99m teboroxime kit | INJECTABLE;INJECTION | 019928-001 | Dec 19, 1990 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription